Richard Van Den Broek Phase Bio Pharmaceuticals Inc (PHAS) insider trading activity

Richard Van Den Broek is Director of PhaseBio Pharmaceuticals Inc. Currently has a direct ownership of 0 shares of PHAS, which is worth approximately $0. The most recent transaction as insider was on May 19, 2023, when has been sold 3,750 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Richard van den Broek Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
May 19 2023	BUY Grant, award, or other acquisition	-	3,750 Added 100.0%	0 Common Stock

Also insider at

PLSE

Pulse Biosciences, Inc. Healthcare

Director

Rvd